We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

Back to rankings

113 hedge funds and large institutions have $1.26B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2013 Q2 according to their latest regulatory filings, with 113 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

174% more call options, than puts

Call options by funds: $74K | Put options by funds: $27K

Holders
113
Holders Change
+113
Holders Change %
–
% of All Funds
3.69%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
113
Increased
–
Reduced
–
Closed
–
Calls
$74K
Puts
$27K
Net Calls
+$47K
Net Calls Change
+$47K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity International
1
Fidelity International
Bermuda
$135M +$125M +6,420,139 New
Schroder Investment Management Group
2
Schroder Investment Management Group
United Kingdom
$128M +$119M +6,107,665 New
Wellington Management Group
3
Wellington Management Group
Massachusetts
$79.2M +$73.6M +3,771,602 New
BCIM
4
Black Creek Investment Management
Ontario, Canada
$73.8M +$68.8M +3,521,865 New
CBOA
5
Commonwealth Bank of Australia
Australia
$68.9M +$64.1M +3,281,833 New
JP Morgan Chase
6
JP Morgan Chase
New York
$61.3M +$56.9M +2,916,723 New
Fidelity Investments
7
Fidelity Investments
Massachusetts
$59.2M +$55M +2,819,515 New
CI Investments Inc
8
CI Investments Inc
Ontario, Canada
$58.8M +$54.7M +2,801,205 New
CWAM
9
Columbia Wanger Asset Management
Illinois
$56.9M +$52.9M +2,708,477 New
BG
10
BlackRock Group
United Kingdom
$41.2M +$38.3M +1,963,351 New
Invesco
11
Invesco
Georgia
$41.1M +$38.2M +1,958,471 New
Bank of New York Mellon
12
Bank of New York Mellon
New York
$39.3M +$36.6M +1,872,870 New
William Blair & Company
13
William Blair & Company
Illinois
$36M +$33.4M +1,712,635 New
CCM
14
Century Capital Management
Massachusetts
$30.5M +$28.4M +1,452,163 New
Bank of America
15
Bank of America
North Carolina
$23M +$21.4M +1,094,594 New
TM
16
Tiger Management
New York
$18.7M +$17.4M +891,618 New
Jennison Associates
17
Jennison Associates
New York
$16.1M +$15M +767,299 New
Principal Financial Group
18
Principal Financial Group
Iowa
$15.3M +$14.2M +727,763 New
PPA
19
Parametric Portfolio Associates
Washington
$14.8M +$13.8M +706,216 New
RG
20
Renaissance Group
Kentucky
$13.9M +$13M +663,964 New
Ninety One (UK)
21
Ninety One (UK)
United Kingdom
$13.8M +$12.8M +656,880 New
O
22
OppenheimerFunds
New York
$13.1M +$12.2M +625,750 New
QBFM
23
QS Batterymarch Financial Management
New York
$12.4M +$11.5M +589,350 New
OAM
24
Oxford Asset Management
United Kingdom
$11.3M +$10.5M +538,248 New
BTP
25
Bloom Tree Partners
New York
$10.9M +$10.1M +517,074 New
1
2 3 4 5

WX Hedge Fund Activity: Q2 2013 in Review

113 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q2 2013, worth a combined $1.26B.

Buyers outnumbered sellers: 113 funds opened new WX positions and 0 closed out — a net gain of 113 holders — while 0 added to existing stakes and 0 trimmed.

  • 113 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.26B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q2 2013.
  • 113 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q2 2013 and 0 closed out, a net change of +113 holders.

Based on aggregated 13F filings for Q2 2013.